CD38 and cancer: To determine activation status of total T cells and SARS-CoV-2 tetramer-specific T cells, we assessed activation markers CD38, HLA-DR, and proliferative marker CD71, as well as TIM-3 and PD-1, linked to T cell exhaustion in chronic diseases and cancers (47).